This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pilote, L.
Right arrow Articles by Eisenberg, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pilote, L.
Right arrow Articles by Eisenberg, M. J.
Related Collections
Right arrow Other health policy
Right arrow Drugs: cardiovascular system
CMAJ • August 6, 2002; 167 (3)
© 2002 Canadian Medical Association or its licensors

Research
Recherche

The effects of cost-sharing on essential drug prescriptions, utilization of medical care and outcomes after acute myocardial infarction in elderly patients

Louise Pilote*, Christine Beck*, Hugues Richard* and Mark J. Eisenberg{dagger}

From *the Divisions of Internal Medicine and Clinical Epidemiology, Montreal General Hospital Research Institute, and {dagger}the Divisions of Cardiology and Epidemiology, Jewish General Hospital, Montreal, Que.

Correspondence to: Dr. Louise Pilote, Division of Clinical Epidemiology, Montreal General Hospital, 1650 Cedar Ave., Montreal QC H3G 1A4; fax 514 934-8293; louise.pilote{at}mcgill.ca

Background: After a change in Quebec's policy on drug coverage in August 1996, elderly patients' copayments for prescription drugs increased. We assessed the impact of this drug policy reform on prescribing patterns for essential cardiac medications, utilization of medical care and related health outcomes after acute myocardial infarction.

Methods: Patients at least 65 years of age who experienced acute myocardial infarction between 1994 and 1998 were identified through the Quebec discharge summary database. Drug claims databases were analyzed to determine rates of prescription of essential cardiac medications for cohorts of patients admitted before and after the policy reform. The impact on readmissions for cardiac-related complications, outpatient visits to physicians and emergency departments, and mortality rate was also assessed.

Results: The proportion of patients who received prescriptions for ß-blockers, angiotensin-converting enzyme inhibitors and lipid-lowering drugs increased over time and, more specifically, did not appear to decline with the change in the drug policy. In addition, the policy reform did not appear to affect persistence of drug therapy (the proportion of time for which patients were covered by prescriptions over the year after discharge). There was no within-class shift from more to less expensive drugs. Use of cardiac procedures increased over time, but this increase was unrelated to the date of the policy reform. Finally, rates of readmission for complications, visits to individual physicians and to emergency departments, and mortality rate were unchanged. The findings did not vary with sex or socioeconomic status.

Interpretation: Prescriptions for essential cardiac medications and care related to acute myocardial infarction in elderly patients did not change with increases in out-of-pocket copayment, regardless of sex or socioeconomic status.




This article has been cited by other articles:


Home page
 CMAJHome page
V. Demers BSc, M. Melo BScPharm M, C. Jackevicius PharmD MSc, J. Cox MD, D. Kalavrouziotis MD, S. Rinfret MD MSc, K. H. Humphries DSc, H. Johansen PhD, J. V. Tu MD PhD, and L. Pilote MD PhD
Comparison of provincial prescription drug plans and the impact on patients' annual drug expenditures
Can. Med. Assoc. J., February 12, 2008; 178(4): 405 - 409.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
D. P. Goldman, G. F. Joyce, and Y. Zheng
Prescription Drug Cost Sharing: Associations With Medication and Medical Utilization and Spending and Health
JAMA, July 4, 2007; 298(1): 61 - 69.
[Abstract] [Full Text] [PDF]

Home page
 Med Care Res RevHome page
T. Rice and K. Y. Matsuoka
Book Review: The Impact of Cost-Sharing on Appropriate Utilization and Health Status: A Review of the Literature on Seniors
Med Care Res Rev, December 1, 2004; 61(4): 415 - 452.
[Abstract] [PDF]